Glucocorticoid Metabolism in the Human Fetal Lung: Implications for Lung Development and the Pulmonary Surfactant System
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
It has been nearly 35 years since Liggins and Howie first reported the benefits of antenatal glucocorticoid (GC) treatment to promote the maturation of the human fetal lung, and nearly that long since Pasqualini and colleagues demonstrated that the human fetal lung actively metabolizes GCs. Since that time, our understanding of the effects of GCs on fetal lung maturation and pulmonary surfactant production has increased dramatically. Similarly, characterization of the enzymes involved in GC metabolism has greatly expanded our understanding of GC signaling in target tissues. In man, the biologically active GC (cortisol) and the biologically inactive GC (cortisone) are interconverted by the tissue-specific expression of the type 1 and type 2 11β-hydroxysteroid dehydrogenase enzymes (HSD1 and HSD2). Much of the research on GC metabolism in peripheral target tissues has focused on the role of HSD1 in amplifying the effects of GCs in liver and adipose tissue or on the role of HSD2 in blocking the effects of GCs in the kidney and placenta. In contrast, the role of GC metabolism in modulating the effects of GCs on fetal lung maturation and the pulmonary surfactant system in humans is less understood. The goal of this review article is to present a brief overview of the role of GCs in human fetal lung maturation and pulmonary surfactant production, and to familiarize the reader with the biochemistry of the metabolism of natural and synthetic GCs by the HSD enzymes. In addition, we will review data concerning the expression and activity of the HSD enzymes in the human fetal lung and contrast this to what is known about the HSD enzymes in the fetal rodent lung. Although rodents, rabbits, sheep, and several primates have been invaluable model systems for the study of fetal lung development, we have chosen to largely focus this review on human lung, since there are significant differences in GC metabolism between humans and other species.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liggins, G. C., & Howie, R. N. (1972) · Pediatrics · doi:10.1542/peds.50.4.515 · Cited by 2,544
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated
Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I. (1988) · Science · doi:10.1126/science.2845584 · Cited by 1,628 · cited 1×
“In these tissues, HSD2 has been shown to locally inactivate cortisol, thus preventing illicit occupation of the mineralocorticoid receptor (MR) by cortisol, since the MR has equal affinities for both aldosterone and cortisol [”
Background11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969 · cited 1×
“HSD1 utilizes nicotinamide adenine dinucleotide phosphate (NADPH) as a cofactor in the 11β-oxidoreduction of inactive cortisone to active cortisol [”
Cole, T. J., Blendy, J. A., Monaghan, A. P., Krieglstein, K., Schmid, W., Aguzzi, A., Fantuzzi, G., Hummler, E., Unsicker, K., & Schütz, G. (1995) · Genes & Development · doi:10.1101/gad.9.13.1608 · Cited by 946
Prenatal glucocorticoids and long-term programming
Seckl (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.151u049 · Cited by 825 · cited 1×
“Thus, it appears that humans and rodents differ significantly in the predominance of the type of HSD activity present in the fetal lung. These observations are surprising since the HSD enzymes in both species carry out the same biochemical reactions and since GCs are thought to play similar roles in the development of…”
BackgroundPREMATURE DELIVERY OF FOETAL LAMBS INFUSED WITH GLUCOCORTICOIDS
LIGGINS, G. C. (1969) · Journal of Endocrinology · doi:10.1677/joe.0.0450515 · Cited by 817
Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need
Muglia, L., Jacobson, L., Dikkes, P., & Majzoub, J. A. (1995) · Nature · doi:10.1038/373427a0 · Cited by 524 · cited 1×
“The critical role of GCs in fetal lung development has been highlighted in a number of studies using mouse genetic models. Mice bearing targeted disruptions of genes encoding corticotrophin-releasing hormone and the glucocorticoid receptor (GR) display delayed lung development as a result of decreased endogenous GC re…”
BackgroundPlasma binding proteins as mediators of corticosteroid action in vertebrates
Breuner, C., & Orchinik, M. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750099 · Cited by 457 · cited 1×
“Circulating plasma levels of free cortisol are approximately 100-fold lower than those of free cortisone, in large part because a significant amount of cortisol remains reversibly bound to corticosteroid binding globulins (i.e., transcortin) and other plasma proteins [”
BackgroundTannin, G. M., Agarwal, A. K., Monder, C., New, M. I., & White, P. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55351-5 · Cited by 436
Grossmann, C., Scholz, T., Rochel, M., Bumke-Vogt, C., Oelkers, W., Pfeiffer, A., Diederich, S., & Bahr, V (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510397 · Cited by 212 · cited 1×
“Additionally, two recent studies have demonstrated that the 11-keto metabolite of Dex (11-dehydro Dex) can compete for GC binding to the GR and act as a potent GR agonist [ , , ,”
BackgroundDiederich, S., Eigendorff, E., Burkhardt, P., Quinkler, M., Bumke-Vogt, C., Rochel, M., Seidelmann, D., Esperling, P., Oelkers, W., & Bähr, V. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020970 · Cited by 154 · cited 1×
“GC action in peripheral tissues is thought to be regulated by (1) the activation/inhibition of the hypothalamic-pituitary-adrenal (HPA) axis (i.e., physiological feedback mechanisms regulating adrenal GC biosynthesis and release), (2) the reversible binding of cortisol to transcortin, and/or (3) the differential expre…”
BackgroundHirasawa, G., Sasano, H., Takahashi, K.-I., Fukushima, K., Suzuki, T., Hiwatashi, N., Toyota, T., Krozowski, Z. S., & Nagura, H. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4337 · Cited by 85
Cortisol and cortisone metabolism in the human foeto-placental unit at midgestation
Pasqualini, J. R., Nguyen, B. L., Uhrich, F., Wiqvist, N., & Diczfalusy, E. (1970) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(70)90016-6 · Cited by 83 · cited 1×
“Thus the biological activity of the 11-hydroxy and 11-keto metabolites of prednisolone seem to parallel that of the natural GC, cortisol, and not that of Dex. Whether other synthetic GCs, such as betamethasone, are also active in their 11-keto forms is currently unknown. HSD Expression and Activity in the Developing H…”
BackgroundLi, K. X. Z., Obeyesekere, V. R., Krozowski, Z. S., & Ferrari, P. (1997) · Endocrinology · doi:10.1210/endo.138.7.5232 · Cited by 44 · cited 1×
“Mutations in the HSD2 gene result in increased levels of cortisol in the renal epithelia and this leads to constitutive transactivation of the MR and the syndrome of apparent mineralocorticoid excess [ , , , , , ,”
Background11β-Hydroxysteroid Dehydrogenase Type 2 and Mineralocorticoid Receptor in Human Fetal Development
Hirasawa, G., Sasano, H., Suzuki, T., Takeyama, J., Muramatu, Y., Fukushima, K., Hiwatashi, N., Toyota, T., Nagura, H., & Krozowski, Z. S. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.4.5615 · Cited by 34 · cited 1×
“subsequently observed that cultured human fetal lung cells actively converted cortisone to cortisol, whereas oxidation of cortisol was undetectable (table 1 ).In the late 1970s and early 1980s, the issue of cortisol metabolism by the human fetal lung was re-examined in a number of in vitro studies by Murphy[ , , ,”
Background
Cited by
Van den Bergh, B. R. H., van den Heuvel, M. I., Lahti, M., Braeken, M., de Rooij, S. R., Entringer, S., Hoyer, D., Roseboom, T., Räikkönen, K., King, S., et al. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.07.003 · Cited by 1,181
Prenatal stress and brain development
Charil, A., Laplante, D. P., Vaillancourt, C., & King, S. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.06.002 · Cited by 559
Smith, R. (2007) · New England Journal of Medicine · doi:10.1056/nejmra061360 · Cited by 411
Ishimoto, H., & Jaffe, R. B. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0001 · Cited by 379
“Conflicting data exist regarding the length of gestation in patients with CAH.”
BackgroundInfluentialGlucocorticoid metabolism in the developing lung: adrenal-like synthesis pathway
Provost, P. R., Boucher, E., & Tremblay, Y. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.03.004 · Cited by 31
“A review on 11-HSD1 and 11-HSD2 activities in fetal lungs was published in 2006 [27].”
BackgroundResultInfluential
Metadata
- Authors
- Garbrecht, M. R., Klein, J. M., Schmidt, T. J., & Snyder, J. M.
- Venue
- Neonatology
- Publisher
- S. Karger AG
- Published
- 2006
- Volume
- 89
- Issue
- 2
- Pages
- 109-119
- ISSN
- 1661-7800 (ISSN-L)
- 1661-7819
- OpenAlex
- W2125036607
- Cited by
- 72
- References
- 16
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.